Larry Dillaha

Affiliations

  • Interim President And Ceo at Repros Therapeutics Inc. (RPRX), 2017-02-13
  • Chief Medical Officer at Insys Therapeutics Inc. (INSY), 2014-03-07
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
INSY $76.25 15,954 $1,216,492.50 3,125 2014-03-05 Filing
INSY $77.24 17,863 $1,379,738.12 19,079 2014-03-05 Filing
INSY $78.59 2,304 $181,071.36 36,942 2014-03-05 Filing
INSY $79.81 3,811 $304,155.91 39,246 2014-03-05 Filing
INSY $80.25 5,717 $458,789.25 43,057 2014-03-05 Filing